(Q45827702)

English

Virtual and in vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against xanthine oxidase and cyclooxygenase-2 for gout treatment

scientific article published in April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Virtual and in vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against xanthine oxidase and cyclooxygenase-2 for gout treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

1 reference

based on heuristic

inferred from title

author name string

Yadi Li

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Christopher M Frenz

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Zhiwen Li

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Mianhua Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Yurong Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Fengjuan Li

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Cheng Luo

7

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Jian Sun

8

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Lars bohlin

9

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Zhenjing Li

10

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Hua Yang

11

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Changlu Wang

12

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

publication date

1 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Chemical Biology and Drug Design

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

81

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

537-544

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

Pathogenesis of Gout

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

The past four decades of progress in the knowledge of gout, with an assessment of the present status

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

Long-term efficacy of hyperuricaemia treatment in renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

The biochemistry and medical significance of the flavonoids

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

Multi-target therapeutics: when the whole is greater than the sum of the parts

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

From magic bullets to designed multiple ligands

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

Pain management in gout

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

Drug discovery: a historical perspective

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

GEMDOCK: a generic evolutionary method for molecular docking.

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

Virtual screening for novel COX-2 inhibitors using the ZINC database

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

The influence of electronic, steric and hydrophobic properties of flavonoid compounds in the inhibition of the xanthine oxidase

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.1248

21 January 2018

Identifiers

10.1111/CBDD.1248

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23534413

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45827702&oldid=2084830233"